The FDA granted priority review to rusfertide, a potential therapy for polycythemia vera; a decision regarding approval is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results